Vialafil 675 mg
On sale on the US market (according to the DSLD)
NewtonEverett, food supplement from the US market
Vialafil 675 mg (NewtonEverett), a food supplement au code-barres 818423027920, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- NewtonEverett
- Barcode
- 818423027920
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Gelatin, Titanium Dioxide, FD&C Blue #1, Magnesium Stearate, Silicon Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Zinc | Mineral | 15 mg |
| Xanthomonnier Blend | Blend | 1,350 mg |
| L-Arginine Hydrochloride | Amino acid | not stated |
| Epimedium Leaf, Stem Extract | Plant | not stated |
| Eleuthero Root Extract (Eleutherococcus senticosus) | Plant | not stated |
| Maca Root Extract (Lepidium meyenii) | Plant | not stated |
| Yohimbe Bark Extract (Pausinystalia johimbe) | Plant | not stated |
| Cnidium monnieri Seed Extract (Cnidium monnieri) | Plant | not stated |
| Xanthoparmelia scabrosa Whole Plant Extract | Other | not stated |
| Catuaba bark extract | Plant | not stated |
| Oat Straw Whole Herb Extract (Avena sativa) | Plant | not stated |
| Muira Puama Bark Extract (Ptychopetalum olacoides) | Plant | not stated |
| Ginkgo biloba leaf extract | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Vialafil
Entered into DSLD on 22 June 2023. Withdrawn from the US market on 19 March 2024 (according to the DSLD).- Active ingredient added : Epimedium extract (quantity not stated)
- Active ingredient added : Oat Straw extract (quantity not stated)
- Active ingredient added : Xanthoparmelia scabrosa extract (quantity not stated)
- Active ingredient removed : Epimedium Leaf, Stem Extract (quantity not stated)
- Active ingredient removed : Oat Straw Whole Herb Extract (quantity not stated)
- Active ingredient removed : Xanthoparmelia scabrosa Whole Plant Extract (quantity not stated)
Official label: Vialafil
Entered into DSLD on 22 May 2021. Withdrawn from the US market on 18 May 2022 (according to the DSLD).- Active ingredient added : Catuaba extract (quantity not stated)
- Active ingredient added : Cnidium monnieri extract (quantity not stated)
- Active ingredient added : Eleuthero extract (quantity not stated)
- Active ingredient added : Epimedium extract (quantity not stated)
- Active ingredient added : Ginkgo biloba extract (quantity not stated)
- Active ingredient added : Maca extract (quantity not stated)
- Active ingredient added : Muira Puama extract (quantity not stated)
- Active ingredient added : Oat Straw extract (quantity not stated)
- Active ingredient added : Xanthoparmelia scabrosa extract (quantity not stated)
- Active ingredient added : Yohimbe extract (quantity not stated)
- Active ingredient removed : Catuaba bark extract (quantity not stated)
- Active ingredient removed : Cnidium monnieri Seed Extract (quantity not stated)
- Active ingredient removed : Eleuthero Root Extract (quantity not stated)
- Active ingredient removed : Epimedium Leaf, Stem Extract (quantity not stated)
- Active ingredient removed : Ginkgo biloba leaf extract (quantity not stated)
- Active ingredient removed : Maca Root Extract (quantity not stated)
- Active ingredient removed : Muira Puama Bark Extract (quantity not stated)
- Active ingredient removed : Oat Straw Whole Herb Extract (quantity not stated)
- Active ingredient removed : Xanthoparmelia scabrosa Whole Plant Extract (quantity not stated)
- Active ingredient removed : Yohimbe Bark Extract (quantity not stated)
Official label: Vialafil 675 mg
Entered into DSLD on 25 January 2020. Withdrawn from the US market on 9 April 2021 (according to the DSLD).- Active ingredient added : Catuaba (Trichilia catigua) extract (quantity not stated)
- Active ingredient added : Cnidium monnieri extract (quantity not stated)
- Active ingredient added : Eleuthero extract (quantity not stated)
- Active ingredient added : Epimedium (Epimedium sagittatum) extract (quantity not stated)
- Active ingredient added : Ginkgo biloba extract (quantity not stated)
- Active ingredient added : Maca (Lepidium meyenii) extract (quantity not stated)
- Active ingredient added : Muira Puama extract (quantity not stated)
- Active ingredient added : Oat Straw extract (quantity not stated)
- Active ingredient added : Xanthoparmelia scabrosa extract (quantity not stated)
- Active ingredient added : Yohimbe extract (quantity not stated)
- Active ingredient removed : Catuaba bark extract (quantity not stated)
- Active ingredient removed : Cnidium monnieri Seed Extract (quantity not stated)
- Active ingredient removed : Eleuthero Root Extract (quantity not stated)
- Active ingredient removed : Epimedium Leaf, Stem Extract (quantity not stated)
- Active ingredient removed : Ginkgo biloba leaf extract (quantity not stated)
- Active ingredient removed : Maca Root Extract (quantity not stated)
- Active ingredient removed : Muira Puama Bark Extract (quantity not stated)
- Active ingredient removed : Oat Straw Whole Herb Extract (quantity not stated)
- Active ingredient removed : Xanthoparmelia scabrosa Whole Plant Extract (quantity not stated)
- Active ingredient removed : Yohimbe Bark Extract (quantity not stated)
Official label: Vialafil 1350 mg
Entered into DSLD on 25 January 2018. Withdrawn from the US market on 30 December 2019 (according to the DSLD).- Active ingredient added : Catuaba (quantity not stated)
- Active ingredient added : Cnidium (quantity not stated)
- Active ingredient added : Eleuthero extract (quantity not stated)
- Active ingredient added : Epimedium sagittatum (quantity not stated)
- Active ingredient added : Ginkgo biloba extract (quantity not stated)
- Active ingredient added : Maca extract (quantity not stated)
- Active ingredient added : Muira Puama extract (quantity not stated)
- Active ingredient added : Oat Straw extract (quantity not stated)
- Active ingredient added : Xanthoparmelia scabrosa (quantity not stated)
- Active ingredient added : Yohimbe extract (quantity not stated)
- Active ingredient removed : Catuaba bark extract (quantity not stated)
- Active ingredient removed : Cnidium monnieri Seed Extract (quantity not stated)
- Active ingredient removed : Eleuthero Root Extract (quantity not stated)
- Active ingredient removed : Epimedium Leaf, Stem Extract (quantity not stated)
- Active ingredient removed : Ginkgo biloba leaf extract (quantity not stated)
- Active ingredient removed : Maca Root Extract (quantity not stated)
- Active ingredient removed : Muira Puama Bark Extract (quantity not stated)
- Active ingredient removed : Oat Straw Whole Herb Extract (quantity not stated)
- Active ingredient removed : Xanthoparmelia scabrosa Whole Plant Extract (quantity not stated)
- Active ingredient removed : Yohimbe Bark Extract (quantity not stated)
- Same quantity, different name: Xanthomonnier Blend (Combination) in this version; Xanthomonnier Blend on the displayed label (1,350 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Eleuthero Root Extract
Read the warning, when it applies and the studies cited
ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS
Route of administration: Oral (ESCOP 2003; Bradley 1992)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
Contraindications
Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).
Sources cited by Health Canada (5)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
- Maca Root Extract
Read the warning, when it applies and the studies cited
Maca - Lepidium Meyenii
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Applies to products providing 0.6 g or more dried root/hypocotyl, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).
Sources cited by Health Canada (1)
- Valentova K, Stejskal D, Bartek J, Dvoráckova S, Kren V, Ulrichova J, Simanek V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment. Food and Chemical Toxicology 2008;46(3):1006-1013. PubMed Randomised trial
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
Sources cited by Health Canada (2)
- Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomised trial
- Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed
Condition of application: Healthy mood balance; Sexual health.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
Sources cited by Health Canada (3)
- Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Archives of Sexual Behavior 2010;39(2):221-239. PubMed Review article
- Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomised trial
- Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : NewtonEverett
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.